GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Other Income (Expense)

Star Lake Bioscience Co (SHSE:600866) Other Income (Expense) : ¥-209 Mil (TTM As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Other Income (Expense)?

Star Lake Bioscience Co's other income expense for the Star Lake Bioscience Co's pretax income for the three months ended in Mar. 2024 was ¥-24 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-209 Mil.


Star Lake Bioscience Co Other Income (Expense) Historical Data

The historical data trend for Star Lake Bioscience Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Other Income (Expense) Chart

Star Lake Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.45 -5.80 -33.98 -180.82 -203.60

Star Lake Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.79 -31.89 22.00 -174.93 -24.03

Star Lake Bioscience Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-209 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Star Lake Bioscience Co  (SHSE:600866) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Star Lake Bioscience Co (SHSE:600866) Business Description

Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines